NCT00072410

Who might be able to join this trial:

• You have been diagnosed with a specific type of ovarian cancer (non-mucinous ovarian adenocarcinoma), confirmed by a lab test on tissue.
• Your ovarian cancer (Stage 3) has come back or has not fully gone away after treatment with platinum- and taxane-based chemotherapy, and the cancer is inside the abdomen.
• The remaining cancer in your body is smaller than 2 cm (about the size of a small grape).
• Your recent blood tests and other lab results (taken within the last 2 weeks) show that your blood counts, liver, kidney, lung, and heart function are all within acceptable ranges (confirm specific values with trial site).
• You are generally able to carry out normal daily activities, as measured by a standard health performance scale (Karnofsky score of 70 or above).
• You are willing and able to sign a written consent form agreeing to take part in the trial.
• You are able to have a small tube (catheter) placed inside your abdomen during surgery as part of the treatment.

Who may not be able to join:

• Your cancer has spread to organs outside the abdomen (Stage IV disease).
• You have cancer that has spread outside the abdomen and is causing symptoms.
• The cancer has spread to your brain or spinal cord.
• You have significant heart disease that limits your daily activities (confirm with trial site).
• A recent heart test (ECG) shows a serious irregular heartbeat or signs of a previous heart attack.
• You have other serious health conditions, such as an active serious infection requiring antibiotics, or a bleeding disorder that may make surgery or the treatment unsafe.
• You have a long-term inflammatory bowel condition (such as Crohn's disease or ulcerative colitis).
• You have received chemotherapy, biological therapy, or immunotherapy within the last 4 weeks before joining the trial.
• You are currently pregnant or breastfeeding.
• You have previously received a certain type of antibody treatment (murine monoclonal antibody), or a blood test shows your immune system may react against the treatment used in this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.